Skip to main content
$3.13 $0.20 (6.8%)

04:00 PM EDT on 05/19/22

Assertio Holdings, Inc. (NASDAQ:ASRT)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Current Price $3.13 Mkt Cap $133.1M
Open $2.91 P/E Ratio 43.50
Prev. Close $3.13 Div. (Yield) $0.00 (0.0%)
Daily Range $2.90 - $3.13 Volume 1,304,369
52-Wk Range $0.85 - $3.52 Avg. Daily Vol. 1,049,961

Caps

How do you think NASDAQ:ASRT will perform against the market?

Add Stock to CAPS Watchlist

All Players

239 Outperform
13 Underperform
 

All-Star Players

26 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ASRT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

VladimirPoutine (< 20)
Submitted February 06, 2022

Turn around and highly profitable.

ssbb123 (28.42)
Submitted February 22, 2010

"Cancer risk" can't see this being a good investment for the next few months at least.http://www.forbes.com/2010/02/18/xenoport-glaxosmithkline-depomed-markets-equities-pharmaceuticals.html?partner=yahootix

NASDAQ:ASRT VS S&P 500 (SPY)

Fools bullish on NASDAQ:ASRT are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ASRT.

Recs

1
Member Avatar VladimirPoutine (< 20) Submitted: 2/6/2022 2:43:28 PM : Outperform Start Price: $2.39 NASDAQ:ASRT Score: +43.92

Turn around and highly profitable.

Recs

1
Member Avatar NorthSeaAscend (99.73) Submitted: 7/24/2018 11:30:16 PM : Outperform Start Price: $8.18 NASDAQ:ASRT Score: -100.27

volatile.

Recs

2
Member Avatar zarrpac (< 20) Submitted: 6/25/2017 6:59:24 AM : Outperform Start Price: $11.11 NASDAQ:ASRT Score: -131.56

Value of its products worth more than its current market value. Temporary overhang caused by pricing pressures on pharmaceuticals.

Leaderboard

Find the members with the highest scoring picks in ASRT.

Score Leader

zzlangerhans

zzlangerhans (99.78) Score: +420.75

The FDA approval curse claims yet another victim.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
anticitradeshort 27.88 4/20/2009 Underperform NS $2.14 +45.79% +359.94% +314.15 0 Comment
ZeroDotCom 23.29 10/9/2009 Underperform 5Y $5.80 -46.21% +265.14% +311.34 0 Comment
BuyTheDip 22.80 10/13/2009 Underperform 5Y $3.90 -20.00% +262.58% +282.58 0 Comment
joebowler210 92.27 10/14/2009 Underperform 3M $3.73 -16.35% +258.15% +274.50 0 Comment
WorldOnFire 26.50 2/2/2011 Underperform 3W $8.31 -62.45% +198.60% +261.06 0 Comment
Stormwind 93.91 4/13/2020 Outperform 5Y $0.79 +293.94% +40.39% +253.55 0 Comment
drugtrader 56.45 4/21/2020 Outperform 5Y $0.83 +276.40% +41.91% +234.49 0 Comment
reed127 < 20 6/14/2012 Underperform 1Y $4.99 -37.47% +194.23% +231.70 0 Comment
ssbb123 28.42 2/22/2010 Underperform 3M $2.46 +26.82% +249.50% +222.68 1 Comment
PDTBiotech 69.93 9/28/2012 Underperform NS $5.86 -46.76% +171.19% +217.95 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ASRT.